Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders, Neuroscience and Neuropharmacology Research, and Multiple Sclerosis Research Studies.
Cognitive Deficits in Anti-LGI1 Encephalitis Are Linked to Immunotherapy-Resistant White Matter Network Changes
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2
Brain atrophy patterns in anti-IgLON5 disease
Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models
Biallelic <i>LGI1</i> and <i>ADAM23</i> variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis
Heterogeneity of anti-Caspr2 antibodies: specificity and pathogenicity
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
NMDA receptor autoantibodies primarily impair the extrasynaptic compartment
Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity
KCNA2 IgG autoimmunity in neuropsychiatric diseases
Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent models
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
Converging synaptic and network dysfunctions in distinct autoimmune encephalitis
Molecular dissection of an immunodominant epitope in Kv1.2-exclusive autoimmunity
Hippocampal hub failure is linked to long-term memory impairment in anti-NMDA-receptor encephalitis: insights from structural connectome graph theoretical network analysis
Brain-targeting autoantibodies in patients with dementia
Patient-Reported Outcome Measures in NMDA Receptor Encephalitis
High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke
Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes
Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial
Identification of a Therapeutic Window for Neurovascular Unit Repair after Experimental Spinal Cord Injury
Obsessive–compulsive symptoms and brain lesions compatible with multiple sclerosis
Evolution from viral encephalitis to autoimmune encephalitis to multiple sclerosis: a case report
Anti-septin complex positive autoimmune encephalitis after severe falciparum malaria: a case report
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome
Fighting Post-COVID and ME/CFS – development of curative therapies
Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome